Work Here?
Ferring Pharmaceuticals
Work Here?
Develops peptide hormone-based medicines and therapies
Ferring Pharmaceuticals
Work Here?
Develops peptide hormone-based medicines and therapies
Overview
Ferring Pharmaceuticals develops medicines that use the body's own peptide hormones, focusing on specialties such as reproductive health, gastroenterology, and urology. Its products range from hormone-based therapies to newer gene-based treatments, such as Adstiladrin for bladder cancer. The company achieves its solutions through research-driven development and manufacturing, including synthetic production of peptide hormones (historically oxytocin and vasopressin) and ongoing expansion of production and clinical programs. Ferring differentiates itself by remaining privately held to pursue a long-term research vision, growing through organic expansion and strategic acquisitions while maintaining a global footprint (over 100 countries, 7,000+ employees). Its goal is to advance therapies that leverage the body's biology to treat diseases more effectively, supported by a sustained investment in R&D and manufacturing, with a future focus on bioengineered and gene-based approaches.
About Ferring Pharmaceuticals
Industries
Biotechnology
Healthcare
Company Size
5,001-10,000
Company Stage
Debt Financing
Total Funding
$302.5M
Headquarters
Saint-Prex, Switzerland
Founded
1950
Get referred to Ferring Pharmaceuticals
See people who can refer or advise you
Simplify's Take
What believers are saying
- Adstiladrin expands Ferring into uro-oncology gene therapy with high-value specialty potential.
- Manufacturing sites in the U.S. and India strengthen supply resilience and localization.
- Global footprint across 100-plus countries supports commercialization and diversified growth.
What critics are saying
- GI competition from AbbVie compresses share and pricing in core gastroenterology markets.
- Adstiladrin faces payer pressure and niche adoption limits in bladder cancer.
- Manufacturing quality failures could trigger warning letters or import alerts across sites.
What makes Ferring Pharmaceuticals unique
- Private ownership supports long-term R&D across peptide-based specialty medicines.
- Leader in reproductive medicine, with heritage in gastroenterology and urology.
- Early pioneer in synthetic oxytocin and vasopressin production since 1961.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$302.5M
Above
Industry Average
Funded Over
2 Rounds
Benefits
Health Insurance
Dental Insurance
Vision Insurance
Disability Insurance
Life Insurance
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Tuition Reimbursement
Paid Sick Leave
Paid Vacation
Paid Holidays
Parental Leave
Hybrid Work Options
Growth & Insights and Company News
6 month growth
↑ 6%1 year growth
↑ 6%2 year growth
↑ 6%Register for the Motility Symposium - 18 september 2026. Posted Monday July 6, 2026 A great day is planned for the 2026 Motility Symposium including sessions on Upper GI and Gastric, Mid/Lower Tract Physiology & Endoscopy, and Systemic * Psychogastroenterology. See the full programme below. Registration for the event is $520.00 and incudes a dinner following the symposium at Ayrburn. Gallery. Monday July 6, 2026 Demo Content Events + 1 More In late July the NZSG Executive Committee will be meeting to consider the Strategic Plan for 2027 to 2032 Monday July 6, 2026 Demo Content Events The 2026 NZSG IBD Symposium is proudly sponsored by Pharmaco and Ferring, taking place in Wellington. Monday July 6, 2026 Demo Content Gastroenterologists across Aotearoa are welcome to participate in a national validation study evaluating an AI assisted...
Ferring Service Center expansion. Ferring continues to grow its investment in Portugal. Ferring/AICEP 26/03/2026 The Ferring Service Center has recently expanded its office space, further reinforcing its commitment to offering a healthy, inclusive, and highly collaborative work environment for all employees. This expansion increases its capacity and positions Portugalglobal to continue growing in a strong and sustainable way.
Ferring announces new Ambition, Enterprise Model and Executive Committee composition to accelerate growth and innovation.
Ferring Pharmaceuticals is Hiring for 28 Jobs on Simplify!
Find jobs on Simplify and start your career today
About Ferring Pharmaceuticals
Industries
Biotechnology
Healthcare
Company Size
5,001-10,000
Company Stage
Debt Financing
Total Funding
$302.5M
Headquarters
Saint-Prex, Switzerland
Founded
1950
Ferring Pharmaceuticals is Hiring for 28 Jobs on Simplify!
Find jobs on Simplify and start your career today